Abstract:T cells play important roles in the pathogenesis of inflammatory bowel diseases (IBD). And ubiquitination and deubiquitination are important epigenetic modifications in immune responses. The process of how USP16 (ubiquitin carboxyl-terminal hydrolase 16) regulates the intestinal inflammation has never been explored. USP16 expression in isolated PBMCs and intestinal tissues of IBD patients and healthy controls were examined by quantitative real-time PCR (qRT-PCR) and immunohistochemistry respectively. T-cell-specific USP16 knockout mouse was generated with the Cre/LoxP technology. Colitis was induced in Rag1−/− mice by transfer of CD4+CD25-CD45RBhi T cells from C57/Bl6 or transgenic mice. T cells were isolated from mice, and the T-cell characteristics were analysed by flow cytometry and qRT-PCR. We used western blot and calcium flux to seek for the substrate of USP16, and immunoprecipitation and immunofluorescence were used to confirm the interaction. Plasmid transfection to the HEK293T cells and mass spectrometry were used to find the ubiquitinated point on the substrate. IBD patients and inflamed intestinal tissues have higher levels of USP16 than controls. T-cell-specific USP16-knockout mice exhibited less severe colitis and less CD4+ T cells infiltration than the C57/Bl6 mice. USP16-deficient T cells had homeostasis dysregulation, impaired proliferation, defected differentiation, and normal migration ability. The calcium-triggered deubiquitination of calcineurin A (CNA), encoded by Ppp3cb or Ppp3cc, in a manner consistent with these defects. We found that the CNA is constitutively ubiquitinated on lysine 327 and that the resulting polyubiquitin chain is rapidly removed by USP16 in response to intracellular calcium stimulation. The K29-linked ubiquitination of CNA impaired NFAT recruitment and the transcription of NFAT-targeted genes. Our work elucidates the physiological function of calcineurin ubiquitination and its deubiquitinase USP16 in peripheral T cells. Notably, our results provide a critical mechanism for the regulation of calcineurin activity and a novel immunosuppressive drug target for the treatment of IBD.

The Role of E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory Bowel Disease: Friend or Foe?

Anti-cytokine Therapy and Small Molecule Agents for the Treatment of Inflammatory Bowel Disease

The regulation role of protein ubiquitination in the development and progression of intestinal inflammation

Quantitative Proteomic Analysis Reveals the Deregulation of Nicotinamide Adenine Dinucleotide Metabolism and CD38 in Inflammatory Bowel Disease.

Ubiquitin-specific Proteases in Inflammatory Bowel Disease-Related Signalling Pathway Regulation

Role of RING-Type E3 Ubiquitin Ligases in Inflammatory Signalling and Inflammatory Bowel Disease

P037 USP16-mediated deubiquitination of calcineurin A controls peripheral T cells maintenance and attenuates intestinal inflammation

Ubiquitination Regulation of Inflammatory Responses Through NF-κB Pathway.

Interplay of Intestinal Microbiota and Mucosal Immunity in Inflammatory Bowel Disease: a Relationship of Frenemies

Role of miRNAs in pathogenesis of inflammatory bowel disease

Role of MicroRNAs in Regulating T Cell Responses in Inflammatory Bowel Disease

Emerging Role of Protein Modification in Inflammatory Bowel Disease.

An (Anti)-Inflammatory Microbiota: Defining the Role in Inflammatory Bowel Disease?

The role of mesenchymal stem cells in attenuating inflammatory bowel disease through ubiquitination

E3 Ubiquitin Ligase RNF183 is a Novel Regulator in Inflammatory Bowel Disease

Indispensable Role of the Ubiquitin-fold Modifier 1-Specific E3 Ligase in Maintaining Intestinal Homeostasis and Controlling Gut Inflammation

Integration of Gut Mycobiota and Oxidative Stress to Decipher the Roles of C-Type Lectin Receptors in Inflammatory Bowel Diseases

The role of ubiquitination in health and disease

Role of Incretin Axis in Inflammatory Bowel Disease

The Deubiquitinase OTUD1 Inhibits Colonic Inflammation by Suppressing RIPK1-mediated NF-κB Signaling

Ubiquitin ligase enzymes and de-ubiquitinating enzymes regulate innate immunity in the TLR, NLR, RLR, and cGAS-STING pathways